BENEFIT FROM ANTI-EGFR THERAPY IN KRAS, BRAF, NRAS, PI3KCA "ALL WILD TYPE", EGFR POSITIVE COLORECTAL CANCER PATIENTS.

被引：0
|
作者：
De Maglio, Giovanna [1 ]
Aprile, Giuseppe [2 ]
Foltran, Luisa [2 ]
Masiero, Elena [1 ]
Lutrino, Stefania [2 ]
Cardellino, Giovanni [2 ]
Fontanella, Caterina [2 ]
Fasola, Gianpiero [2 ]
Pizzolitto, Stefano [1 ]
机构：
[1] Univ Hosp, Dept Pathol, Udine, Italy
[2] Univ Hosp, Dept Oncol, Udine, Italy
来源：
ANNALS OF ONCOLOGY | 2011年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：v107 / v107
页数：1
相关论文
共 50 条
  • [21] Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
    Sandra Misale
    Rona Yaeger
    Sebastijan Hobor
    Elisa Scala
    Manickam Janakiraman
    David Liska
    Emanuele Valtorta
    Roberta Schiavo
    Michela Buscarino
    Giulia Siravegna
    Katia Bencardino
    Andrea Cercek
    Chin-Tung Chen
    Silvio Veronese
    Carlo Zanon
    Andrea Sartore-Bianchi
    Marcello Gambacorta
    Margherita Gallicchio
    Efsevia Vakiani
    Valentina Boscaro
    Enzo Medico
    Martin Weiser
    Salvatore Siena
    Federica Di Nicolantonio
    David Solit
    Alberto Bardelli
    Nature, 2012, 486 : 532 - 536
  • [22] Overall survival of patients with metastatic KRAS wild type colorectal cancer patients treated with anti-EGFR third line monotherapy
    Debska-Szmich, Sylwia
    Krakowska, Magdalena
    Staniecka, Katarzyna
    Krzeptowska, Paulina
    Debski, Jakub
    Dzierzak, Maria
    Wasik, Magdalena
    Gadzinowska, Joanna
    Habib-Lisik, Maja
    ONCOLOGY IN CLINICAL PRACTICE, 2022, 18 (06): : 402 - 405
  • [23] Beyond KRAS status and response to anti-EGFR therapy in metastatic colorectal cancer
    Perkins, Geraldine
    Pilati, Camilla
    Blons, Helene
    Laurent-Puig, Pierre
    PHARMACOGENOMICS, 2014, 15 (07) : 1043 - 1052
  • [24] Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer
    Misale, Sandra
    Yaeger, Rona
    Hobor, Sebastijan
    Scala, Elisa
    Janakiraman, Manickam
    Liska, David
    Valtorta, Emanuele
    Schiavo, Roberta
    Buscarino, Michela
    Siravegna, Giulia
    Bencardino, Katia
    Cercek, Andrea
    Chen, Chin-Tung
    Veronese, Silvio
    Zanon, Carlo
    Sartore-Bianchi, Andrea
    Gambacorta, Marcello
    Gallicchio, Margherita
    Vakiani, Efsevia
    Boscaro, Valentina
    Medico, Enzo
    Weiser, Martin
    Siena, Salvatore
    Di Nicolantonio, Federica
    Solit, David
    Bardelli, Alberto
    NATURE, 2012, 486 (7404) : 532 - U131
  • [25] Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal antibody therapy for RAS wild-type metastatic colorectal cancer
    Rowland, A.
    Dias, M. M.
    Wiese, M. D.
    Kichenadasse, G.
    McKinnon, R. A.
    Karapetis, C. S.
    Sorich, M. J.
    BRITISH JOURNAL OF CANCER, 2015, 112 (12) : 1888 - 1894
  • [26] Meta-analysis of BRAF mutation as a predictive biomarker of benefit from anti-EGFR monoclonal antibody therapy for RAS wild-type metastatic colorectal cancer
    A Rowland
    M M Dias
    M D Wiese
    G Kichenadasse
    R A McKinnon
    C S Karapetis
    M J Sorich
    British Journal of Cancer, 2015, 112 : 1888 - 1894
  • [27] A method to assess KRAS/BRAF genotype in patients with metastatic colorectal cancer (mCRC) elligible for anti-EGFR therapies
    Lamy, A.
    Labourier, E.
    Prigneau, O.
    Di Fiore, F.
    Sesbouea, R.
    Sabourin, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (04)
  • [28] The occurrence of mutant KRAS clones in the blood of RAS wild type colorectal cancer patients - impact of response or failure under anti-EGFR therapy
    Berger, A. W.
    Schwerdel, D.
    Welz, H.
    Moeller, P.
    Ettrich, T. J.
    Seufferlein, T.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 14 - 14
  • [29] Prognostic Value of BRAF, PI3K, PTEN, EGFR Copy Number, Amphiregulin and Epiregulin Status in Patients with KRAS Codon 12 Wild-Type Metastatic Colorectal Cancer Receiving First-Line Chemotherapy with Anti-EGFR Therapy
    Llovet, Patricia
    Sastre, Javier
    Sanz Ortega, Julian
    Bando, Inmaculada
    Ferrer, Milagros
    Garcia-Alfonso, Pilar
    Donnay, Olga
    Carrato, Alfredo
    Jimenez, Ana
    Aranda, Enrique
    Leon, Ana
    Gravalos, Cristina
    Carlos Camara, Juan
    Feliu, Jaime
    Sanchiz, Barbara
    Caldes, Trinidad
    Diaz-Rubio, Eduardo
    MOLECULAR DIAGNOSIS & THERAPY, 2015, 19 (06) : 397 - 408
  • [30] Prognostic Value of BRAF, PI3K, PTEN, EGFR Copy Number, Amphiregulin and Epiregulin Status in Patients with KRAS Codon 12 Wild-Type Metastatic Colorectal Cancer Receiving First-Line Chemotherapy with Anti-EGFR Therapy
    Patricia Llovet
    Javier Sastre
    Julián Sanz Ortega
    Inmaculada Bando
    Milagros Ferrer
    Pilar García-Alfonso
    Olga Donnay
    Alfredo Carrato
    Ana Jiménez
    Enrique Aranda
    Ana León
    Cristina Grávalos
    Juan Carlos Cámara
    Jaime Feliú
    Bárbara Sanchíz
    Trinidad Caldés
    Eduardo Díaz-Rubio
    Molecular Diagnosis & Therapy, 2015, 19 : 397 - 408
12345